id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-1978-0007,FDA,FDA-2019-E-1978,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2023-11-15T05:00:00Z,2023,11,2023-11-15T05:00:00Z,,2023-11-15T18:56:04Z,,0,0,090000648627e385
FDA-2019-E-1978-0006,FDA,FDA-2019-E-1978,Determination of Regulatory Review Period for Purposes of Patent Extension; DOPTELET,Notice,Determinations,2023-02-06T05:00:00Z,2023,2,2023-02-06T05:00:00Z,2023-04-08T03:59:59Z,2024-02-05T14:00:04Z,2023-02482,0,0,0900006485633e6e
FDA-2019-E-1978-0005,FDA,FDA-2019-E-1978,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2023-02-02T05:00:00Z,2023,2,2023-02-02T05:00:00Z,,2023-02-02T15:39:19Z,,0,0,090000648562ca75